HighVista Strategies’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-1,862
Closed -$202K – 140
2018
Q4
$202K Sell
1,862
-1,281
-41% -$172K 0.17% 106
2018
Q3
$469K Buy
3,143
+931
+42% +$142K 0.22% 79
2018
Q2
$341K Sell
2,212
-232
-9% -$35K 0.15% 97
2018
Q1
$340K Sell
2,444
-350
-13% -$51.4K 0.15% 107
2017
Q4
$383K Sell
2,794
-1,047
-27% -$138K 0.11% 141
2017
Q3
$498K Sell
3,841
-699
-15% -$93.2K 0.11% 131
2017
Q2
$601K Buy
+4,540
New +$556K 0.14% 108
2015
Q2
– Sell
-2,098
Closed -$227K – 174
2015
Q1
$227K Sell
2,098
-1,233
-37% -$127K 0.04% 163
2014
Q4
$309K Buy
+3,331
New +$294K 0.04% 125

Other funds holding LH

HighVista Strategies's LH Position: Q1 2019 in Review

HighVista Strategies sold out of Labcorp (LH) in Q1 2019, closing a stake of 1,862 shares — an estimated $202K sold.

HighVista Strategies first reported a position in LH in Q4 2014 and held it in 9 quarters. The position peaked at $601K in Q2 2017. 745 funds tracked by Wall St. Rank hold LH as of Q1 2019.

  • HighVista Strategies reported no remaining Labcorp position as of Q1 2019 after selling out during the quarter.
  • HighVista Strategies sold 1,862 Labcorp shares in Q1 2019, an estimated $202K.
  • HighVista Strategies first reported a position in Labcorp in Q4 2014 and held it in 9 quarters.
  • HighVista Strategies's Labcorp position peaked at $601K in Q2 2017.
  • 745 funds tracked by Wall St. Rank held Labcorp as of Q1 2019.

Based on HighVista Strategies's 13F filing for Q1 2019, filed 15 May 2019.